Meena Madhur
@cvimmunology.bsky.social
Cardiovascular physician-scientist, mom, wife, mentor and mentee for life. I believe in science. Fascinated by the immune system. Posts are my own.
Can’t wait to welcome you to Indiana University! Congratulations Dr Sugi!
Dr. Ariane Imulinde Sugi successfully defended her dissertation last week. So proud of her and the rest of the Lindsey Lab! Next stop: @cvimmunology.bsky.social
July 26, 2025 at 9:57 PM
Can’t wait to welcome you to Indiana University! Congratulations Dr Sugi!
Reposted by Meena Madhur
ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism
#nephsky
www.ahajournals.org/doi/10.1161/...
#nephsky
www.ahajournals.org/doi/10.1161/...
ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism | Hypertension
BACKGROUND: Primary aldosteronism (PA) is a distinct cause of low-renin hypertension (LRH), characterized
by inappropriate aldosterone production. We investigated the distinction between LRH
and PA by...
www.ahajournals.org
April 1, 2025 at 11:43 AM
ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism
#nephsky
www.ahajournals.org/doi/10.1161/...
#nephsky
www.ahajournals.org/doi/10.1161/...
Reposted by Meena Madhur
#Takotsubo Syndrome: Expanding Insights, Unanswered Questions
By ACC Magazine
#CardioSky #MedSky
@accintouch.bsky.social
www.acc.org/Latest-in-Ca...
By ACC Magazine
#CardioSky #MedSky
@accintouch.bsky.social
www.acc.org/Latest-in-Ca...
December 3, 2024 at 2:37 PM
#Takotsubo Syndrome: Expanding Insights, Unanswered Questions
By ACC Magazine
#CardioSky #MedSky
@accintouch.bsky.social
www.acc.org/Latest-in-Ca...
By ACC Magazine
#CardioSky #MedSky
@accintouch.bsky.social
www.acc.org/Latest-in-Ca...
Congratulations to my friend and colleague @brandimwynne.bsky.social on this prestigious #award from ASPET! Well deserved!
January 30, 2025 at 9:11 PM
Congratulations to my friend and colleague @brandimwynne.bsky.social on this prestigious #award from ASPET! Well deserved!
Reposted by Meena Madhur
Interesting interactive case presentation on an under-recognized cause of hypertension. @anandvaidya17.bsky.social @nejm.org
www.nejm.org/doi/10.1056/...
www.nejm.org/doi/10.1056/...
Targeting a Hormonal Cause of Hypertension | NEJM
This interactive feature describes a woman who received a diagnosis of hypertension
and preeclampsia at 27 years of age. After giving birth, her blood pressure remained
elevated. Test your diagnost...
www.nejm.org
January 25, 2025 at 10:16 PM
Interesting interactive case presentation on an under-recognized cause of hypertension. @anandvaidya17.bsky.social @nejm.org
www.nejm.org/doi/10.1056/...
www.nejm.org/doi/10.1056/...
Congratulations @djfehrenbach.bsky.social ! This is a significant achievement and well deserved!
December 20, 2024 at 5:29 PM
Congratulations @djfehrenbach.bsky.social ! This is a significant achievement and well deserved!
Reposted by Meena Madhur
🚨 🔬 Your #muscle remembers! 🧠💪 New 📑 by Pilotto et al. reveals that high-intensity interval training imprints an epigenetic memory in human skeletal muscles 🚴♂️📈 Even after 3 months of rest! #HIIT #Epigenetics #MuscleMemory
#Kickback for the #holiday😉?!?
journals.physiology.org/doi/abs/10.1...
#Kickback for the #holiday😉?!?
journals.physiology.org/doi/abs/10.1...
Human skeletal muscle possesses an epigenetic memory of high intensity interval training | American Journal of Physiology-Cell Physiology
INTRODUCTION: Human skeletal muscle displays an epigenetic memory of resistance exercise induced by hypertrophy. It is unknown, however, whether high-intensity interval training (HIIT) also evokes an ...
journals.physiology.org
November 22, 2024 at 12:01 PM
🚨 🔬 Your #muscle remembers! 🧠💪 New 📑 by Pilotto et al. reveals that high-intensity interval training imprints an epigenetic memory in human skeletal muscles 🚴♂️📈 Even after 3 months of rest! #HIIT #Epigenetics #MuscleMemory
#Kickback for the #holiday😉?!?
journals.physiology.org/doi/abs/10.1...
#Kickback for the #holiday😉?!?
journals.physiology.org/doi/abs/10.1...
#HerAcademicVoice I want to highlight this website and initiative by my friend and colleague Dr Sotto. Check out these profiles of women of color and invite them to speak, collaborate, and learn from them. Spread the word.
www.sylksotto.com/heracademicv...
www.sylksotto.com/heracademicv...
Meet the Experts at Sylk Sotto Consulting
Discover the dedicated professionals at Sylk Sotto Consulting, committed to advancing inclusive excellence in healthcare.
www.sylksotto.com
November 21, 2024 at 5:50 PM
#HerAcademicVoice I want to highlight this website and initiative by my friend and colleague Dr Sotto. Check out these profiles of women of color and invite them to speak, collaborate, and learn from them. Spread the word.
www.sylksotto.com/heracademicv...
www.sylksotto.com/heracademicv...
Reposted by Meena Madhur
We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how:
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
Action Intent Links | Bluesky
Authors, websites, and apps can use action intent links to implement "Share on Bluesky" buttons, or similar in-app actions. Logged-in users will be directed to the corresponding action view in the Blu...
docs.bsky.app
November 18, 2024 at 2:48 PM
We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how:
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
Reposted by Meena Madhur
#LBCT #SUMMIT trial #AHA24
💥 Treatment with tirzepatide led to ⤵️risk of a composite of death from cardiovascular 🫀 causes or worsening heart failure 🆚 placebo and improved health status in patients with HFpEF+obesity
📎 @NEJM www.nejm.org/doi/full/10....
💥 Treatment with tirzepatide led to ⤵️risk of a composite of death from cardiovascular 🫀 causes or worsening heart failure 🆚 placebo and improved health status in patients with HFpEF+obesity
📎 @NEJM www.nejm.org/doi/full/10....
November 16, 2024 at 3:16 PM
#LBCT #SUMMIT trial #AHA24
💥 Treatment with tirzepatide led to ⤵️risk of a composite of death from cardiovascular 🫀 causes or worsening heart failure 🆚 placebo and improved health status in patients with HFpEF+obesity
📎 @NEJM www.nejm.org/doi/full/10....
💥 Treatment with tirzepatide led to ⤵️risk of a composite of death from cardiovascular 🫀 causes or worsening heart failure 🆚 placebo and improved health status in patients with HFpEF+obesity
📎 @NEJM www.nejm.org/doi/full/10....
Reposted by Meena Madhur
Despite Primary Aldosteronism being the most common etiology of secondary HTN in middle-aged adults, <2% of the eligible population is ever screened!
Really need to start doing more PRA & Aldo levels on our patients with poorly-controlled HTN, risk factors (see below)
Really need to start doing more PRA & Aldo levels on our patients with poorly-controlled HTN, risk factors (see below)
November 12, 2024 at 7:27 PM
Despite Primary Aldosteronism being the most common etiology of secondary HTN in middle-aged adults, <2% of the eligible population is ever screened!
Really need to start doing more PRA & Aldo levels on our patients with poorly-controlled HTN, risk factors (see below)
Really need to start doing more PRA & Aldo levels on our patients with poorly-controlled HTN, risk factors (see below)
Reposted by Meena Madhur
The 2024 ESC guideline says all-comers with HTN. It’s been shown to be cost-effective across all-comers. I think Greg Hundemer’s work on the target organ effects of subclinical primary aldo is compelling 👇. I’ve been checking anyone with uncontrolled HTN
www.ahajournals.org/doi/10.1161/...
www.ahajournals.org/doi/10.1161/...
Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study | Circulation
BACKGROUND: Primary aldosteronism, characterized by overt renin-independent aldosterone production,
is a common but underrecognized form of hypertension and cardiovascular disease. Growing
evidence su...
www.ahajournals.org
November 13, 2024 at 1:02 AM
The 2024 ESC guideline says all-comers with HTN. It’s been shown to be cost-effective across all-comers. I think Greg Hundemer’s work on the target organ effects of subclinical primary aldo is compelling 👇. I’ve been checking anyone with uncontrolled HTN
www.ahajournals.org/doi/10.1161/...
www.ahajournals.org/doi/10.1161/...